RINVOQ 30 mg prolonged-release tablets
- Licence status
- Active substances
- Upadacitinib Hemihydrate
- Dosage Form
- Prolonged-release tablet
- Licence number
- EU/1/19/1404/006-009
- Licence holder
- AbbVie Deutschland GmbH & Co. KG
Product documents
Licence information
- ATC code
- L04AA Selective immunosuppressants, L04AA44 upadacitinib
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 16/12/2019